(Q39330359)

11 September 2017

title

Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines (English)

1 reference

11 September 2017

1 reference

Leishmania donovani

1 reference

S Decuypere

10

0 references

Manu Vanaerschot

object named as

M Vanaerschot

2

0 references

Shyam Sundar

4

object named as

S Sundar

1 reference

11 September 2017

M Ouakad

1

1 reference

11 September 2017

S Rijal

3

1 reference

11 September 2017

N Speybroeck

5

1 reference

11 September 2017

L Kestens

6

1 reference

11 September 2017

L Boel

7

1 reference

11 September 2017

S De Doncker

8

1 reference

11 September 2017

I Maes

9

1 reference

11 September 2017

J-C Dujardin

11

1 reference

11 September 2017

publication date

8 August 2011

1 reference

11 September 2017

1 reference

11 September 2017

volume

138

1 reference

11 September 2017

issue

11

1 reference

11 September 2017

page(s)

1392-1399

1 reference

Fitness of drug-resistant malaria parasites

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Cooperation between apoptotic and viable metacyclics enhances the pathogenesis of Leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility?

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

In vitro stimulation of metacyclogenesis in Leishmania braziliensis, L. donovani, L. major and L. mexicana

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

In vitro life cycle of pentamidine-resistant amastigotes: stability of the chemoresistant phenotypes is dependent on the level of resistance induced

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Metacyclogenesis in Leishmania promastigotes

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Lower nitric oxide susceptibility of trivalent antimony-resistant amastigotes of Leishmania infantum

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Prioritizing emerging zoonoses in the Netherlands

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Evaluation of an in vitro and in vivo model for experimental infection with Leishmania (Viannia) braziliensis and L. (V.) peruviana

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Pentavalent antimonials: new perspectives for old drugs

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Leishmania: overexpression and comparative structural analysis of the stage-regulated meta 1 gene

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Antibiotic resistance and its cost: is it possible to reverse resistance?

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Transcriptomics throughout the life cycle of Leishmania infantum: high down-regulation rate in the amastigote stage.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Metabolomics to unveil and understand phenotypic diversity between pathogen populations

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Classification trees versus multinomial models in the analysis of urban farming systems in Central Africa

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Gene expression profiling of Leishmania (Leishmania) donovani: overcoming technical variation and exploiting biological variation.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Skewing of cytokine profiles towards T helper cell type 2 response in visceral leishmaniasis patients unresponsive to sodium antimony gluconate

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Linking in vitro and in vivo survival of clinical Leishmania donovani strains

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Drug resistance in Indian visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Leishmania spp.: proficiency of drug-resistant parasites

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Leishmaniasis: current situation and new perspectives

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Flow cytometric assessment of Leishmania spp metacyclic differentiation: Validation by morphological features and specific markers

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Evidence-based semiquantitative methodology for prioritization of foodborne zoonoses

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

Cell differentiation and infectivity of Leishmania mexicana are inhibited in a strain resistant to an ABC-transporter blocker

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011001120

7 January 2021

10.1017/S0031182011001120

Identifiers

DOI

1 reference

11 September 2017

1 reference